The Fedeli Group, one of Ohio’s largest independent employee benefits and risk management consulting firms, has acquired KAZ Company, an Independence, Ohio based brokerage firm focused on Medicare education and service. [Read more…]
Chubb Earns Highest Customer Satisfaction Rating
Chubb has earned the highest customer satisfaction rating in the J.D. Power 2020 U.S. Small Commercial Insurance Study. Chubb is receiving this prestigious award based on its performance in five key customer satisfaction factors including claims, interaction, billing and payment, policy offerings, and pricing. [Read more…]
Study Says Medicare Subscribers Say Health Routines Important
More than half (57%) of Medicare subscribers believe daily health routines are more important now than in years past, and 76% are interested in using plan benefits and incentives to help them maintain preventive health habits. The findings were published today in the 2020 Medicare Study from InComm Payments, a survey of more than 2,500 Medicare subscribers conducted in Nov. 2020. [Read more…]
Providence Therapeutics COVID-19 Vaccine Receives Authorization
Providence Therapeutics has announced that Health Canada has provided a Notice of Authorization for its Clinical Trial Application. [Read more…]
Aurobindo Pharma and COVAXX Agreement
Aurobindo Pharma Limited (NSE: AUROPHARMA) (BSE: 524804) (Reuters: ARBN.NS) (Bloomberg: ARBP:IN) and COVAXX, a US-based company, have entered into an Exclusive License Agreement to develop, commercialize and manufacture UB-612, the first Multitope Peptide-based Vaccine to fight COVID-19, for India and the United Nations Children’s Fund (UNICEF) agency. [Read more…]
Sputnik V Vaccine Delivered to Argentina
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the delivery of the first batch of 300,000 doses of Sputnik V, the world’s first registered vaccine against coronavirus, to Argentina. [Read more…]
INOVIO Publication of Phase 1 Data COVID-19 DNA Vaccine Candidate
INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, has announced the publication of peer-reviewed Phase 1 clinical data from the first cohort of 40 participants for its COVID-19 DNA vaccine candidate, INO-4800, in EClinicalMedicine, an open access clinical journal published by The Lancet. [Read more…]
COVID-19 Variant from South Africa Identified
Two cases of a new SARS-CoV-2 variant, which originated in South Africa, have been identified in the UK. [Read more…]
January 1 is Life Time’s Commitment Day
Millions of Americans set lofty resolutions and fitness goals to kick off 2020…which were promptly kicked to the curb when the COVID-19 pandemic turned our lives upside down. [Read more…]
Therap introduces Interface with Sandata Aggregator
Therap Services, the long-standing national leader providing software solutions for HIPAA-compliant electronic documentation for providers in Home and Community Based Services (HCBS) and the broader Long Term Services and Supports (LTSS), introduces its Sandata Aggregator Interface for providers in Arizona. [Read more…]